Researchers at Weill Cornell Medicine have used artificial intelligence to identify drug targets based on mapping regulatory networks in patient tumors. The study, published in Cell Systems, experimentally identified and ...
Sep 5, 2024
0
32
Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers.
Sep 4, 2024
0
36
The ROS1 tyrosine kinase inhibitor (TKI) taletrectinib demonstrated high overall and intracranial responses, and a favorable safety profile with low incidence of neurologic adverse events in TKI-naive and TKI-pretreated patients ...
Sep 10, 2024
0
0
A combination therapy improved progression-free survival in patients with metastatic castration-resistant prostate cancer with distinct genetic mutations compared to either therapy alone or sequentially, according to results ...
Sep 9, 2024
0
0
The HER2-specific tyrosine kinase inhibitor zongertinib was well tolerated and demonstrated promising efficacy in patients with HER2 mutation-positive non-small cell lung cancer, meeting the primary endpoint of the Beamion ...
Sep 9, 2024
0
0
A new survey finds the majority of American men believe the first step in prostate cancer screening is an invasive rectal exam by their doctor.
Sep 9, 2024
0
1
Data from a Phase 3 study has revealed that ivonescimab demonstrates a statistically significant and clinically meaningful improvement in progression-free survival compared to pembrolizumab for patients with PD-L1-positive ...
Sep 8, 2024
0
0
The antibody–drug conjugate ifinatamab deruxtecan (I-DXd) has shown clinically meaningful responses in pretreated patients with extensive-stage small cell lung cancer (ES-SCLC), according to an interim analysis of the Phase ...
Sep 7, 2024
0
0
Research published online by the Journal of the National Comprehensive Cancer Network (JNCCN) finds that for many commonly-used treatment regimens targeting metastatic gastrointestinal (GI) cancers, such as FOLFOX, FOLFIRI, ...
Sep 5, 2024
0
0
New insights into the biology of kidney cancer, including those informed by scientific discoveries that earned a Nobel Prize, have led to advances in treatment and increased survival rates, according to a review by UNC Lineberger ...
Aug 28, 2024
0
0
